The trademark application PASSAGE BIO was filed by Passage Bio, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 11, 2020, and it was registered by office on June 18, 2020 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021. Change of name and professional address of the trademark registration was recorded on October 13, 2021. Change of name and professional address of the trademark registration was recorded on August 6, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies
Pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders
Pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system
Medicines for human purposes, namely, for treating genetically based diseases and disorders
Viral vectors for use in the delivery of gene therapy
Viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases
Pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development
Clinical research in the field of genetic medicine, gene therapy and regenerative medicines
Testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines
Biological information analysis, namely, genetic testing for medical research purposes
Scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases
Providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials
Medical and scientific research, namely, conducting clinical trials for others
Compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease.
The mark was filed in class 44 with following description of goods:
Providing medical information
Providing medical information in the field of gene therapy, genetic medicines, regenerative medicines, biologics, pharmaceutical-gene interactions and the treatment of genetically based diseases
Providing a website via a global computer network featuring information in the fields of health, diseases, disease detection, diagnosis and treatment.